Campus, Miralyn .

HRN: 27-29-25  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2025
CEFUROXIME 1.5GM (VIAL)
06/11/2025
06/13/2025
IV
1.5
Q8
SP LTCS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: